3640 results for «553»
3640 results
How can we improve the management of aortic stenosis in 2026?
19 May 2026 – From EuroPCR 2026
As aortic stenosis management continues to evolve, this EuroPCR 2026 session looks ahead to the challenges and opportunities shaping clinical practice in 2026. From implementing the latest guidelines in daily care to refining the timing of intervention, the discussion focuses on how earlier identification and treatment...
Beyond the horizon - A prelude into TAVI and complex PCI solutions
19 May 2026 – From EuroPCR 2026
This session provides a comprehensive preview of evolving technologies and strategies shaping interventional cardiology. Discover the Myval Octapro+ transcatheter heart valve (THV) and its innovative design and procedural benefits demonstrated through a recorded case. Stay updated on Landmark and Compare TAVI trial data, and discover the...
From referral to discharge: European consensus on the TAVI care pathway
19 May 2026 – From EuroPCR 2026
Across Europe, TAVI programmes are under increasing pressure from rising demand, capacity limits and referral barriers. This EuroPCR 2026 session presents the European consensus on the TAVI care pathway and explores how data-driven, standardised approaches can optimise the patient journey from referral to discharge.
Bringing together clinicians,...
TAVI and coronary artery disease: we need the COMPLETE answer!
19 May 2026 – From EuroPCR 2026
Addressing the intersection of transcatheter aortic valve implantation (TAVI) and coronary artery disease, this session reviews contemporary surgical and interventional literature to elucidate current practices. It underscores the need for a large international randomized controlled trial to provide definitive guidance for managing patients with concomitant aortic...
Large-bore venous access and vessel closure: all you need to know
19 May 2026 – From EuroPCR 2026
This session provides a comprehensive guide to large-bore venous access and vessel closure techniques, emphasizing best practices and the advantages of ultrasound-guided suture mediated vessel closure compared to traditional figure-of-eight suture methods. It also addresses strategies to avoid and manage potential complications encountered during these procedures.
DCB in contemporary PCI: evidence, technique and physiology-guided decision-making
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the evolving role of drug-coated balloons (DCB) in contemporary PCI, highlighting how growing clinical evidence, refined procedural strategies and physiology-guided tools are reshaping everyday practice.
The discussion reviews the latest data supporting DCB use, including long-term outcomes from major registries and trials...
Evolving bifurcation treatment practices: DCB, angio-based FFR and side branch optimisation
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores the evolving landscape of bifurcation PCI, focusing on drug-coated balloon (DCB) strategies, angio-based fractional flow reserve (FFR) and side branch optimisation. It highlights how new evidence and physiology-guided tools are reshaping decision-making in this complex lesion subset.
Discussions include insights from the...
Interventional therapy for hypertension
19 May 2026 – From EuroPCR 2026
This session addresses interventional therapies for hypertension, emphasizing patient selection for renal denervation and integration of this technique within comprehensive hypertension management. It also reviews available renal denervation technologies, optimal procedural approaches, and considerations for interventional treatment of renal artery stenosis.
CTO PCI: how to prevent and manage complications effectively?
19 May 2026 – From EuroPCR 2026
Focused on chronic total occlusion (CTO) PCI, this session highlights the critical importance of procedural planning to minimize complications. Through detailed case analyses of coronary dissection and perforation, it outlines early identification strategies and equips clinicians with essential tools and techniques for effective complication management in...
New evidence for pharmacology for coronary artery disease
19 May 2026 – From EuroPCR 2026
This session presents the latest evidence in pharmacological management of coronary artery disease, featuring pivotal trials such as VESALIUS-CV and TARGET FIRST. It covers topics including evolocumab efficacy post-stenting, early aspirin cessation strategies, aspirin-free protocols after complex PCI in ACS, and comparative outcomes of clopidogrel versus...
The thin line between success and failure in MedTech start ups - Lessons learnt
18 May 2026 – From EuroPCR 2026
This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.
AI for clinical and academic cardiology knowledge work: innovation or academic misconduct ? Literature search, data extraction and responsible use
19 May 2026 – From EuroPCR 2026
This session critically examines the role of artificial intelligence in clinical and academic cardiology, focusing on its application in literature search, evidence synthesis, and report structuring. It discusses responsible AI use, emphasizing the balance between assistance and academic integrity, and features a debate on authorship, transparency,...
Artificial intelligence and advanced imaging in coronary interventions
19 May 2026 – From EuroPCR 2026
This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...
Managing complex calcified PCI: pitfalls and complications
20 May 2026 – From EuroPCR 2026
This session addresses the complexities and challenges of performing PCI in heavily calcified coronary lesions. Emphasizing the critical role of imaging in procedural planning, it updates on contemporary tools and techniques to mitigate complications. The session also shares practical experience in managing common complications such as...
Thrombectomy in pulmonary embolism
19 May 2026 – From EuroPCR 2026
This session addresses the critical role of mechanical thrombectomy in managing pulmonary embolism, focusing on rescue interventions in refractory massive acute cases. It explores clinical and technical challenges that extend beyond current guidelines, reviews complex cases including intermediate-high risk pulmonary embolism with peripheral embolism, intracardiac thrombosis,...
Insight from recent evidence in structural heart disease: indications for LAA closure (CHAMPION) and PCI in TAVI candidates (PRO-TAVI)
20 May 2026 – From EuroPCR 2026
This session reviews recent evidence impacting the management of structural heart disease, focusing on left atrial appendage (LAA) closure indications and PCI considerations in transcatheter aortic valve implantation (TAVI) candidates. It discusses optimal strategies for coronary artery disease in TAVI patients and evaluates findings from the...
Rescue techniques for coronary interventions
20 May 2026 – From EuroPCR 2026
This session presents an array of advanced rescue techniques employed in coronary interventions when unexpected complications arise. It features real-world cases including management of complex coronary artery aneurysms, malignant pericardial tamponade, challenging primary PCI scenarios, and innovative bailout strategies such as self-made covered stents and guidewire...
Back to the future - Lessons from the past that can guide contemporary practice
20 May 2026 – From EuroPCR 2026
Reflecting on historical perspectives in the management of atherosclerotic coronary vascular disease, this session imparts valuable lessons to guide contemporary PCI practice. It emphasizes best practices in vessel preparation, evaluates the significance of drug-eluting stents, and provides a pathologist’s insight into mechanisms of PCI failure to...
Innovative strategy in ACS
20 May 2026 – From EuroPCR 2026
Focusing on innovative strategies in acute coronary syndrome (ACS), this session reviews recent advances including drug-coated balloons in STEMI, early discharge safety guided by microcirculatory resistance indices, intravascular lithotripsy for coronary calcification in ACS, and novel stenting protocols demonstrated in randomized trials, providing a comprehensive update...
Debate: how will AI change the cardiology landscape in the next five years?
20 May 2026 – From EuroPCR 2026
Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...